ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

APDN Applied DNA Sciences Inc

0.42
0.0103 (2.51%)
Last Updated: 16:12:03
Delayed by 15 minutes
Share Name Share Symbol Market Type
Applied DNA Sciences Inc NASDAQ:APDN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0103 2.51% 0.42 0.417 0.42 0.42 0.41 0.4199 50,951 16:12:03

Applied DNA Sciences, Inc. Announces Completion of R&D Program to Develop DNA-Embedded Holographic Security Product

08/06/2005 8:05pm

PR Newswire (US)


Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Applied DNA Sciences Charts.
Applied DNA Sciences, Inc. Announces Completion of R&D Program to Develop DNA-Embedded Holographic Security Product LOS ANGELES, June 8 /PRNewswire-FirstCall/ -- Applied DNA Sciences, Inc. (OTC:APDN) (BULLETIN BOARD: APDN) announces the completion of a 6-month R&D program to develop a DNA-embedded hologram. The announcement follows the successful testing of the new DNA-embedded holographic security product by the Department of Energy's Idaho National Laboratory. The holograms were developed under an agreement with Holomex, a leading security hologram supplier, who provided the latest advancements in holographic technology for this project. The goal of the program was to design a multi-layered security product that has both the convenience and speed of optical readability and the absolute certainty of DNA forensic authentication. The DOE produced a conclusive report demonstrating the successful integration of APDN's DNA into a hologram. The most significant outcome of this testing was the increased speed of DNA authentication. The improved analytical methods developed by the DOE under an R&D program with APDN produced positive results 10 times faster than conventional Polymerase Chain Reaction (PCR) methods typically used by commercial laboratories for DNA testing. These new methods are the result of several advancements involving various DNA-encrypted products under a Cooperative Research and Development Agreement (CRADA) that APDN executed with the Department of Energy. The DNA holograms are the first of several product configurations planned under the business alliance with Holomex. APDN and Holomex will target several industry sectors with the new security labels. The pharmaceutical, beauty product, automotive and entertainment industries are the primary targets. Since holograms are already in wide use for security printing, the addition of DNA for forensic authentication has strong appeal, and is a natural progression to meet demands for higher security. Customers already familiar with using holograms will recognize the cost benefits associated with implementing the DNA feature that utilizes existing process equipment-making adoption very fast. Holomex will begin marketing the new DNA holograms to its existing customers in July 2005. ABOUT APPLIED DNA SCIENCES, INC. Applied DNA Sciences, Inc. provides proprietary DNA-embedded security solutions, using plant DNA, to verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion into physical plant and databases. Applied DNA Sciences, Inc., 9229 West Sunset Boulevard Los Angeles, CA 90069; Tel: 310.860.1362; Fax: 310.860.1303. http://www.adnas.com/ . Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the Company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks detailed in the Company's periodic filings as filed with the SEC. DATASOURCE: Applied DNA Sciences, Inc. CONTACT: Adrian Butash of Applied DNA Sciences, Inc., +1-310-860-1362, ; Investor Relations - Tim Clemensen, Senior Vice President, Rubenstein Investor Relations, +1-212-843-9337, ; Public Relations - Jennifer Gould, Vice President, Rubenstein Public Relations, +1-212-843-8037, , both for Applied DNA Sciences, Inc. Web site: http://www.adnas.com/

Copyright

1 Year Applied DNA Sciences Chart

1 Year Applied DNA Sciences Chart

1 Month Applied DNA Sciences Chart

1 Month Applied DNA Sciences Chart

Your Recent History

Delayed Upgrade Clock